Growth Hormone News Update - Saizen® Solution
7 November 2012
In July 2012 the Department ceased ordering Saizen® solution for injection (somatropin) through the Australian Government’s PBS Growth Hormone Program as the supplier had initiated a recall of short dated Saizen®.
The supplier has worked with the Department and the Therapeutic Goods Administration (TGA) to manage this situation and from 2 October 2012 the restriction was lifted.
The Department continues to monitor the situation and patients using Saizen® should ensure that their supply does not expire before the end of their treatment period. If it does, patients should contact their pharmacy and doctor as soon as possible to arrange replacement medicine.
Any questions regarding the current and future availability of Saizen® solution for injection can be addressed to the Growth Hormone Program.
Additional information including Frequently Asked Questions are available on the Department of Health and Ageing website.